What is the interpretation of a total estradiol of 96 pg/mL, follicle‑stimulating hormone (FSH) of 10.5 mIU/mL, and luteinizing hormone (LH) of 10.7 mIU/mL in a reproductive‑age woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interpretation of Hormone Levels

These hormone values suggest normal ovarian function in a reproductive-age woman, with levels consistent with the early-to-mid follicular phase of a normal menstrual cycle.

Detailed Analysis

Estradiol (96 pg/mL)

This estradiol level falls within the normal range for the follicular phase of the menstrual cycle. According to established reference intervals using LC-MS/MS methodology, the early follicular phase (days -15 to -6) ranges from 31-771 pmol/L (approximately 8-210 pg/mL), and the late follicular phase extends up to 1742 pmol/L 1. Your value of 96 pg/mL is well within normal limits and rules out hypoestrogenism, which would typically present with levels below 30 pg/mL 2.

FSH (10.5 mIU/mL)

This FSH level is reassuringly normal for a reproductive-age woman. The critical threshold to understand is that FSH elevation beyond 25 IU/L in a young woman (outside of the pre-ovulation peak) indicates premature ovarian insufficiency (POI) 2. Your level of 10.5 is well below this threshold. Research demonstrates that FSH values measured on cycle days 1-4 are the best single predictor of ovarian reserve, with older reproductive-age women (40-45 years) showing significantly higher values than younger women (20-25 years) 3.

LH (10.7 mIU/mL)

This LH level is within normal range for the follicular phase. The LH:FSH ratio of approximately 1:1 is normal and does not suggest polycystic ovary syndrome (PCOS), which typically presents with an LH:FSH ratio >2 4, 5. During the pre-ovulation peak, both LH and FSH surge together, with estradiol levels classically reaching 150-200 pg/mL per mature follicle 2.

Clinical Context

Timing matters: These values are most interpretable when drawn during the early follicular phase (cycle days 2-5). If drawn at other times in the cycle, interpretation may differ:

  • Mid-cycle: Could represent approaching ovulation (though estradiol would typically be higher, 150-200+ pg/mL)
  • Luteal phase: Would expect higher progesterone levels (not provided here)

What This Rules Out

  • Premature Ovarian Insufficiency: FSH would be ≥25 IU/L with low estradiol (<30 pg/mL) 2
  • PCOS: Would show LH:FSH ratio >2, often with elevated testosterone 4, 5
  • Diminished Ovarian Reserve: Would show FSH >15 IU/L on day 2-3 testing 6

Next Steps Based on Clinical Scenario

If evaluating fertility or ovarian reserve:

  • Consider adding Anti-Müllerian Hormone (AMH) testing, which reflects follicle stock and doesn't vary by menstrual cycle day 2, 7
  • Transvaginal ultrasound for antral follicle count (normal is ≥5 follicles; <5 suggests diminished reserve) 8

If evaluating menstrual irregularity:

  • Check thyroid function (TSH), prolactin, and 17-hydroxyprogesterone to exclude mimics of ovarian dysfunction 5
  • Document menstrual pattern over 6 months 4

If these were drawn randomly (not timed to cycle):

  • Repeat testing on cycle days 2-5 for most accurate baseline assessment 2, 3

Key Pitfall to Avoid

Do not interpret these values if the patient is on combined hormonal contraception or progestins with antigonadotropic action, as FSH will be artificially suppressed and must be rechecked at least 3 months after discontinuation 2.

Related Questions

What does a luteinizing hormone level of 42.8 IU/L, follicle‑stimulating hormone level of 57.7 IU/L, and estradiol level of 22 pg/mL indicate in a 61‑year‑old woman, and what management is recommended?
In a symptomatic woman with follicle‑stimulating hormone 20.7 U/L, estradiol 47.3 pg/mL, luteinizing hormone 8.78 U/L, progesterone <0.34 ng/mL, and testosterone 21.2 ng/dL, how should these hormone levels be interpreted?
When is the optimal time to assess reproductive hormones (estradiol, follicle‑stimulating hormone, luteinizing hormone, testosterone, and progesterone) in a non‑pregnant adult woman not taking exogenous hormones?
What are the normal laboratory reference ranges for follicle‑stimulating hormone (FSH), luteinizing hormone (LH), estradiol (estrogen), and progesterone?
What are the reference laboratory ranges for estradiol, follicle‑stimulating hormone (FSH), and luteinizing hormone (LH) in a postmenopausal woman?
What is the most effective strategy to reduce transmission of vancomycin‑resistant Enterococcus (VRE) from a dialysis patient in the ICU who is VRE‑positive on a prior rectal swab?
How should an otherwise healthy 18‑month‑old with sickle cell trait be managed and counseled?
What is the preferred oral treatment regimen for a geriatric resident in a long-term skilled nursing facility with community-acquired pneumonia, chronic obstructive pulmonary disease (COPD) on chronic oxygen therapy, and no signs of systemic illness?
What treatment recommendations should be given for a nursing home resident with a chest X‑ray negative for pneumonia who has had desaturations requiring increased supplemental oxygen, cough, congestion, and episodes of apnea but no fever or chills?
What is the proper dosing and administration schedule for mirtazapine?
What is Paxil (paroxetine) and what are its indications, dosing, contraindications, and common side effects?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.